BOLALAR GEMODIALIZ BEMORLARIDA ANEMIYANI DAVOLASH  SAMARADORLIGINI BAHOLASH VA ESA GA JAVOBNI PROGNOZLASH

Haydarova O'g'ilshoda

PDF

DOI

Keywords

bolalar gemodializi, anemiya, ESA, eritropoetin, ESA hyporesponsiveness, ERI

How to Cite

BOLALAR GEMODIALIZ BEMORLARIDA ANEMIYANI DAVOLASH SAMARADORLIGINI BAHOLASH VA ESA GA JAVOBNI PROGNOZLASH . (2026). MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE, 4(9), 96-107. https://universalpublishings.com/index.php/mpttp/article/view/20721

Abstract

Ushbu maqolada bolalar gemodializ bemorlarida surunkali buyrak kasalligi bilan bog‘liq anemiyani davolash samaradorligi va eritropoezni stimullovchi agentlarga (ESA) javobni prognozlashning zamonaviy yondashuvlari tahlil qilindi. Tadqiqot strukturaviy adabiyotlar sharhi va dalillar sintezi ko‘rinishida bajarilib, 2026-yilgi KDIGO anemiya bo‘yicha klinik qo‘llanmasi, pediatrik ESA sistematik sharhlari va gemodializdagi bolalarda erythropoietin resistance index (ERI)ni baholagan zamonaviy klinik tadqiqotlar tahlil qilindi.

PDF

DOI

References

1. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. (2026). KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease. Kidney International, 109(Suppl 1S), S1–S99.

2. Atkinson, M. A., & Warady, B. A. (2018). Anemia in children with chronic kidney disease. Pediatric Nephrology / Nature Reviews Nephrology review literature.

3. Use of erythropoiesis-stimulating agents in children with chronic kidney disease: A systematic review. (2022). Pediatric Nephrology / PMC.

4. Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study. (2025). PubMed PMID: 40293460.

5. Resistance to Epoetin-Stimulating Agents in Children Receiving Renal Replacement Therapy. (2024). PubMed PMID: 39690475.